NCR Atleos Corporation Common Stock NATL 深 滬
已收盤 07-25 16:00:00 美东时间
27.51
+1.070
+4.05%
華盛通- 最 高27.54
- 今 開26.66
- 成交量 60.88万股
- 最 低 26.435
- 昨 收 26.44
- 總市值 20.21亿
- 52周最高 35.50
- 市盈率 靜 22.43
- 換手率 0.83%
- 52周最低 22.30
- 委 比 -33.33%
- 總股本 7345.43万
- 歷史最高 35.50
- 量 比 0.41
- 振 幅 4.18%
- 歷史最低 18.415
- 每 手 1
- 風險率 3.64%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Atleos Expands ATM Network in Greece With DirectPay and iXchange Partnership
NCR Atleos Corporation (NYSE:NATL) ("Atleos"), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced that DirectPay and iXchange will utilize Atleos'
07-01 17:07
美股大行评级 | 潜在涨幅378.93%！aTyr Pharma获富国银行升目标价至25美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1143101010774646784.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 富国银行：维持aTyr Pharma(ATYR)"超配"评级，目标价从17美元升至25美元</p> <p>• 摩根大通：维持Array Technologies(ARRY)"超配"评级，目标价从12美元升至13美元</p>
06-21 08:35
Wedbush Initiates Coverage On NCR Atleos with Outperform Rating, Announces Price Target of $35
Wedbush analyst Matt Bryson initiates coverage on NCR Atleos (NYSE:NATL) with a Outperform rating and announces Price Target of $35.
06-20 20:49
Nordic American Tankers Ltd (NYSE: NAT) – Founder, Chairman & CEO buys more shares in NAT
Herbjorn Hansson, Founder, Chairman & CEO of Nordic American Tankers Ltd., purchased 100,000 shares at $2.70 per share on June 2, 2025. After this transaction, the Hansson family now owns 9,400,000 shares, making them the largest private shareholder group in the company.
06-02 13:38
NCR Atleos Affirms FY2025 Adj EPS Guidance of $3.22 vs $4.01 Est; Affirms FY2025 Sales Guidance of $4.32B vs $4.30B Est
NCR Atleos (NYSE:NATL) affirms FY2025 Adj EPS guidance from $3.22 to $3.22 vs $4.01 analyst estimate. Affirms FY2025 sales outlook from $4.32 billion to $4.32 billion vs $4.30 billion estimate.
05-08 04:14
Earnings Scheduled For May 7, 2025
Companies Reporting Before The Bell • Wallbox (NYSE:WBX) is estimated to report...
05-07 16:33
Under the Radar: How Everyday Observations Lead to Exceptional Investments
Peter Lynch, who managed Fidelity’s Magellan Fund from 1977 to 1990, achieved l...
03-26 01:07
NCR Atleos Appoints New Chief Accounting Officer
An update from NCR Atleos, LLC ( ($NATL) ) is now available. NCR Atleos Corpora...
03-19 04:32
美股大行评级 | 美银证券：维持雅培"买入"评级，目标价从133美元升至150美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106501041932570625.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Roth MKM：维持CervoMed Inc.(CRVO)"买入"评级，目标价从7美元升至15美元</p> <p>• Oppenheimer：维持Trevi Therapeutics(TRVI)"跑赢大市"评级，目标价从
03-12 11:01
美股大行评级 | 富国银行：维持艾伯维"超配"评级，目标价从210美元升至240美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1104327819967434752.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 摩根大通：维持Syndax制药(SNDX)"超配"评级，目标价从35美元升至39美元</p> <p>• 摩根大通：维持AnaptysBio(ANAB)"超配"评级，目标价从36美元升至42美元</p> <p>• 摩根大通
03-06 11:20
